GRIFFIN: subgroup analysis of patients with multiple myeloma with high-risk cytogenetics VJHemOnc – Video Journal of Hematology & HemOnc 1:34 2 years ago 280 Скачать Далее
An update on GRIFFIN: D-RVd in patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:17 1 year ago 151 Скачать Далее
Post Hoc Analysis of Sustained MRD Negativity (GRIFFIN Trial) in TE NDMM Patients International Myeloma Foundation 4:05 2 years ago 368 Скачать Далее
Special approaches to myeloma patients with high-risk cytogenetics VJHemOnc – Video Journal of Hematology & HemOnc 2:07 2 years ago 520 Скачать Далее
Updated results of GRIFFIN: D-RVd vs RVd in patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:51 2 years ago 302 Скачать Далее
An analysis on patients with high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:06 2 years ago 741 Скачать Далее
Tandem transplantation for patients with myeloma with high-risk cytogenetics VJHemOnc – Video Journal of Hematology & HemOnc 0:59 2 years ago 265 Скачать Далее
Myeloma: follow-up of GRIFFIN study VJHemOnc – Video Journal of Hematology & HemOnc 1:52 2 years ago 156 Скачать Далее
Current approaches for the management of patients with high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:02 2 years ago 868 Скачать Далее
GRIFFIN updates: D-RVd vs RVd in transplant-eligible patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:13 2 years ago 154 Скачать Далее
GRIFFIN Study: Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone for Multiple Myeloma DocWire 16:06 3 years ago 582 Скачать Далее
Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learn... Multiple Myeloma Hub 13:25 2 years ago 141 Скачать Далее
GRIFFIN: follow-up after DARA + RVd for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:12 3 years ago 242 Скачать Далее
Improving the identification of patients with high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:36 1 year ago 124 Скачать Далее
GRIFFIN Trial Update - DVRd vs VRd in Newly Diagnosed Myeloma | Peter Voorhees, MD | ASH 2021 HealthTree Foundation for Multiple Myeloma 6:07 2 years ago 557 Скачать Далее
High-risk disease biology in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:36 3 years ago 430 Скачать Далее
Dr. Voorhees on Updated Depth of Response in GRIFFIN Trial in Multiple Myeloma OncLive 1:05 4 years ago 81 Скачать Далее
Long-term follow-up results of TOURMALINE-MM2: IRd vs pbo-Rd in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:22 2 years ago 86 Скачать Далее
